Key Insights

Highlights

Treatment Research

1 treatments under study, led by Observation

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Suspended1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02502435SuspendedPrimary

Human Plasma Fatty Acid Oscillations

Showing all 1 trials

Research Network

Common Treatments

  • Observation1

Active Sponsors

  • University of Pennsylvania1

Top Investigators

Related Conditions

  • Healthy1

Activity Timeline